The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
Summary
This episode examines the breakthrough of a new mRNA-based personalized cancer vaccine and the political controversy surrounding the technology in the US. Host Asma Khalid speaks with science writer Tom Whipple about how mRNA, previously validated by COVID-19 vaccines, is now being used to train immune systems to fight skin cancer. They discuss the scientific promise of this programmable technology versus the skepticism and funding cuts driven by Health Secretary RFK Jr., who questions mRNA's efficacy and safety. The conversation highlights the tension between medical innovation and politic…
Topics discussed
Intro: Ads and episode overview on mRNA cancer vaccine
History of mRNA: Katalin Karikó and the Nobel Prize
The new personalized skin cancer vaccine explained
How mRNA technology works and its early struggles
Pandemic acceleration and the rise of skepticism
RFK Jr.'s claims on mRNA efficacy and safety
Side effects, flu vaccines, and FDA approval debates
Funding cuts, national security risks, and conclusion
Listen ad-free on Castria